Fine Control of In Vivo Magnetic Hyperthermia Using Iron Oxide Nanoparticles with Different Coatings and Degree of Aggregation

Fine Control of In Vivo Magnetic Hyperthermia Using Iron Oxide Nanoparticles with Different Coatings and Degree of Aggregation

The clinical implementation of magnetic hyperthermia has experienced little progress since the first clinical trial was completed in 2005. Some of the hurdles to overcome are the reliable production of magnetic nanoparticles with controlled properties and the control of the temperature at the target...

Full description

Bibliographic Details
Main Authors: Yurena Luengo, Zamira V. Díaz-Riascos, David García-Soriano, Francisco J. Teran, Emilio J. Artés-Ibáñez, Oihane Ibarrola, Álvaro Somoza, Rodolfo Miranda, Simó Schwartz, Ibane Abasolo, Gorka Salas
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Pharmaceutics
Subjects:
magnetic hyperthermia
cancer
nanoparticles
controlled heat in vivo
Online Access:https://www.mdpi.com/1999-4923/14/8/1526

Internet

https://www.mdpi.com/1999-4923/14/8/1526

Similar Items